A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

NCT00460941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Placebo
DRUG: Taspoglutide 20mg
DRUG: Taspoglutide 20mg-30mg
DRUG: Taspoglutide 20mg-40mg

Sponsor

Hoffmann-La Roche